Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 15Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Glioblastoma 7Esophageal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Burkitt Lymphoma 7Uterine Cervical Neoplasms 6Rhabdomyosarcoma 6Squamous Cell Carcinoma of Head and Neck 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Sarcoma 3Rhabdomyosarcoma, Embryonal 3Rectal Neoplasms 3Neoplasm Metastasis 3Medulloblastoma 3Lymphoma, Follicular 3Lung Neoplasms 3Hodgkin Disease 3Head and Neck Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Adenocarcinoma of Lung 3Vaginal Neoplasms 2Rhabdomyosarcoma, Alveolar 2Prostate Adenocarcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2

Interventions

Octreotide 3maltodextrin 1lanreotide 1Sulfasalazine 1Radiation 1Probiotics 1Loperamide 1Levofloxacin 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Diarrhea × Radiation × Clear all
NCT00033605 2016-07-13

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Alliance for Clinical Trials in Oncology

Phase 3 Completed
130 enrolled
GastrointestinalGenitourinaryGynecologicSarcoma

Uterine Cervical Neoplasms, Diarrhea, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡